Insiders I-Mab Börse Stuttgart

Equities

Market Closed - Börse Stuttgart Other stock markets 11:36:56 03/07/2024 am IST			5-day change	1st Jan Change
1.45 ^EUR	-2.68%		-6.29%	-8.59%

06/06	I-Mab Appoints Phillip Dennis as Chief Medical Officer	CI
05/06	I-Mab Collaborates With Bristol-Myers to Evaluate Givastomig in Combination Study for Gastric, Esophageal Cancers	MT

I-Mab Appoints Phillip Dennis as Chief Medical Officer	06/06	CI
Verastem Names John Hayslip as Chief Medical Officer	19/04	MT
I-Mab Announces Chief Medical Officer Changes	16/04	CI
I-Mab Announces Executive Resignation	01/04	CI
I-Mab Announces Board Changes , Effective February 10, 2024	07/02	CI
I-Mab Names Raj Kannan CEO	22/23/22	MT
I-Mab Announces CEO Changes	22/23/22	CI
I-Mab Announces the Appointment of Raj Kannan as Member of the Board of Directors	22/23/22	CI
I-Mab Announces Board and Management Changes	03/23/03	CI
I-Mab Announces Management Changes	01/22/01	CI
I-Mab Announces Management Changes	30/22/30	CI
I-Mab Announces Executive Appointments	29/22/29	CI
I-Mab Announces Andrew Zhu Joins as President and Board Director	20/21/20	CI
I-Mab Announces Executive Changes	20/21/20	CI
I-Mab Announces Board Changes, Effective December 10, 2021	11/21/11	CI
I-Mab Names John Long CFO	01/21/01	MT
I-Mab Appoints Jielun Zhu as Chief Strategy Officer	01/21/01	CI
I-Mab Announces Committee Appointments	21/21/21	CI
I-Mab Appoints Andrew Zhu to Its Scientific Advisory Board	21/21/21	CI
I-Mab Announces Executive Appointments	01/21/01	CI

No results for this search